Floatz logo

Mazdutide

Heart Failure With Preserved Ejection Fraction (HFPEF)

Innovent Biologics (Suzhou) Co. Ltd.protein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Heart Failure With Preserved Ejection Fraction (HFPEF) cohort.

Asset / SponsorPhaseRating
Semaglutide
Mayo Clinic
Phase 4BBB
Metformin
Sara ElAdawy
Phase 4BBB
Tirzepatide
Yunlong Wang
Phase 4BBB
Liraglutide
Leiden University Medical Center
Phase 4BBB
BENZBROMARONE
National Defense Medical Center, Taiwan
Phase 4BB

View all 23 →

Same molecule, other indications

Mazdutide is also rated in:

obesity disorderDormant
BB
Indicative ·
70 / 100
View asset →
coronary artery disorderDormant
BB
Indicative ·
65 / 100
View asset →
sleep apnea syndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →